Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amitriptyline for Repetitive Behaviors in ASD
NCT04725383Phase 3Terminated
- Sponsor
- University of Missouri-Kansas City
- Start
- Nov 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amitriptyline in Autism Spectrum Disorder (ASD), sponsored by University of Missouri-Kansas City. Started Nov 2023; status: terminated.
02
Drugs
amitriptyline
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04725383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04725383.